Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study.
Petracca M, Ruggieri S, Barbuti E, Ianniello A, Fantozzi R, Maniscalco GT, Andreone V, Landi D, Marfia GA, Di Gregorio M, Iodice R, Sinisi L, Maida E, Missione R, Coppola C, Bonavita S, Borriello G, Centonze D, Lus G, Pozzilli C, Signoriello E.
Petracca M, et al. Among authors: barbuti e.
Neurol Ther. 2022 Sep;11(3):1193-1208. doi: 10.1007/s40120-022-00364-6. Epub 2022 Jun 2.
Neurol Ther. 2022.
PMID: 35653061
Free PMC article.